Clinical Study Evaluating the Performance of HEMOBLAST Bellows Compared to FLOSEAL Hemostatic Matrix in Cardiothoracic Operations

Inclusion Criteria

• •Subject is undergoing a non-emergent cardiothoracic surgery; and
• •Subject or an authorized legal representative is willing and able to give prior written informed consent for study participation.
• •Subject does not have an active or suspected infection at the surgical site;
• •Subject in whom the Investigator is able to identify a Target Bleeding Site (TBS) for which any applicable conventional means for hemostasis are ineffective or impractical; and
• •Subject has a TBS with minimal, mild, or moderate bleeding